thalidomide has been researched along with Leukocytosis in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Leukocytosis: A transient increase in the number of leukocytes in a body fluid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gau, YC | 1 |
| Hsiao, HH | 1 |
| Liu, YC | 1 |
| Yeh, TJ | 1 |
| Eve, HE | 1 |
| Rule, SA | 1 |
2 other studies available for thalidomide and Leukocytosis
| Article | Year |
|---|---|
Case report of coexistence of myeloproliferative neoplasms and multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bortezomib; Dexameth | 2020 |
Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.
Topics: Antineoplastic Agents; Drug Eruptions; Fatal Outcome; Female; Humans; Lenalidomide; Leukocytosis; Ly | 2010 |